US5015634A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of treating tissue damage with inositol triphosphate
Assignee: Perstorp AB
•
Filing: 1990-03-13
•
Granted: 1991-05-14
•
Expires: 2010-03-13
Abstract
Abstract A method of preventing or alleviating tissue or bone damage in mammals is disclosed. The method comprises administering, to a mammal, a tissue damage or a bone damage preventing or alleviating effective amount of a pharmaceutical composition which includes at least one isomer of inositol trisphosphate.
Inventors
- 👤 Matti Siren
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 21:09
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/66
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
37 words
A method of preventing or alleviating tissue damage comprising administering, to a mammal in need thereof, a tissue damage preventing or alleviating effective amount of a pharmaceutical composition which comprises at least one isomer of inositol triphosphate.
Claim 2
Independent Claim
37 words
A method of preventing or alleviating tissue damage comprising administering, to a mammal in need thereof, a tissue damage preventing or alleviating effective amount of a pharmaceutical composition which comprises at least one isomer of inositol triphosphate.
Claim 3
Dependent Claim
24 words
A method in accordance with claim 1 wherein said tissue damage preventing or alleviating effective amount is an oedema preventing or alleviating effective amount.
Claim 4
Dependent Claim
25 words
A method in accordance with claim 1 wherein said tissue damage preventing or alleviating effective amount is a vascular leakage preventing or alleviating effective amount.
Claim 5
Dependent Claim
25 words
A method in accordance with claim 1 wherein said tissue damage preventing or alleviating effective amount is a burn damage preventing or alleviating effecting amount.
Claim 6
Dependent Claim
22 words
A method in accordance with claim 1 wherein said pharmaceutical composition includes at least one salt of an isomer of inositol triphosphate.
Claim 7
Dependent Claim
27 words
A method in accordance with claim 5 wherein the salt of said isomer of inositol triphosphate is a sodium, a potassium, a calcium or a zinc salt.
Claim 8
Dependent Claim
16 words
A method in accordance with claim 1 wherein said pharmaceutical composition is provided in tablet form.
Claim 9
Dependent Claim
16 words
A method in accordance with claim 1 wherein said pharmaceutical composition is provided in granulated form.
Claim 10
Dependent Claim
16 words
A method in accordance with claim 1 wherein said pharmaceutical composition is provided in solution form.
Claim 11
Dependent Claim
22 words
A method in accordance with claim 1 wherein said isomer is selected from the group consisting of D-myo-inositol-1,2,6-triphosphate, myo-inositol-1,2,3-triphosphate, myo-inositol-1,3-4-triphosphate and L-myo-inositol-1,3,4-triphosphate.
Claim 12
Dependent Claim
12 words
A method in accordance with claim 10 wherein said isomer is D-myo-inositol-1,2,6-triphosphate.
Claim 13
Dependent Claim
23 words
A method in accordance with claim 10 wherein said D-myo-inositol-1,2,6-triphosphate is provided as the sodium, the potassium, the calcium or the zinc salt.
References Cited (Backward Citations)
US2723938A
Cited
US3591665A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-05-13 | 1994-11-12 | 1995-05-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-05-13 | 1998-11-12 | 1999-05-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-05-13 | 2002-11-12 | 2003-05-14 | $7700.00 | Window Closed / Lapsed |